Palatin's Vyleesi® Licensee Fosun Pharma Reports First

/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...

Related Keywords

Taiwan , United States , Kwangdong , Ch Ungch Ong Bukto , South Korea , China , Macau , Hong Kong , Hainan Province , Hainan , Republic Of Korea , South Korean , American , Chinese , Carl Spana , Fosun Pharma , Korean Ministry Of Food Drug Safety , Drug Administration , Kwangdong Pharmaceuticals , Palatin Technologies Inc , Prnewswire Palatin Technologies Inc , Exchange Commission , Securities Exchange , Chinese National Medical Products Administration , Chinese Hainan , Hypoactive Sexual Desire Disorder , Korean Ministry , Drug Safety , Chief Executive Officer , Hainan Free Trade Zone , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Palatin Technologies , Nc ,